Transcriptional regulation of plasminogen activator inhibitor-1 in vascular endothelial cells induced by oxidized very low density lipoproteins

被引:0
作者
Ruozhi Zhao
Xiuli Ma
Garry X. Shen
机构
[1] University of Manitoba,Departments of Internal Medicine and Physiology
[2] University of Manitoba,Diabetes Research Group
来源
Molecular and Cellular Biochemistry | 2008年 / 317卷
关键词
Heat shock factor-1; Oxidized VLDL; Plasminogen activator inhibitor-1; Endothelial cells; Mouse embryo fibroblasts;
D O I
暂无
中图分类号
学科分类号
摘要
Elevated levels of triglycerides and very low density lipoproteins (VLDL) are biochemical markers of metabolic syndrome and diabetes. VLDL from hypertriglyceridemic or diabetic patients increased the generation of plasminogen activator inhibitor-1 (PAI-1) from cultured vascular endothelial cells (EC). Susceptibility of VLDL to peroxidation was increased in diabetic patients. Heat shock factor-1 (HSF1) is implicated in the transcriptional regulation of PAI-1 induced by glycated low density lipoprotein (LDL). The present study examined the effects of oxidized VLDL (oxVLDL) on the expression of PAI-1 and HSF1 in cultured human EC and mouse embryo fibroblasts (MEF). OxVLDL modified by copper or iron ions increased the expression of PAI-1 and HSF1 in EC compared to VLDL or LDL. Butylated hydroxytulene inhibited oxVLDL-induced expression of PAI-1 and HSF1 in EC. OxVLDL increased the binding of HSF1 to PAI-1 promoter. Short interference RNA for HSF1 inhibited oxVLDL-induced PAI-1 expression in EC. OxVLDL stimulated the expression of PAI-1 from MEF of wild-type mice, but failed to increase PAI-1 expression in MEF of HSF1-knockout mice. The results indicate that oxVLDL increased PAI-1 expression, and HSF1 mediates the transcription of PAI-1 in cultured vascular EC or fibroblasts.
引用
收藏
页码:197 / 204
页数:7
相关论文
共 83 条
[1]  
Yuan G(2007)Hypertriglyceridemia: its etiology, effects and treatment Can Med Assoc J 176 1113-1120
[2]  
Al-Shali KZ(1999)Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: cellular aspects Clin Cardiol 22 II7-II14
[3]  
Hegele RA(2006)Effects of VLDL and remnant particles on platelets Pathophysiol Haemost Thromb 35 281-291
[4]  
Gianturco SH(1992)The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis Annu Rev Med 43 219-225
[5]  
Bradley WA(1993)Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk Coron Artery Dis 4 1119-1122
[6]  
Olufadi R(2003)Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes J Am Coll Cardiol 41 360-370
[7]  
Byrne CD(1999)Increased susceptibility to peroxidation of VLDL from non-insulin-dependent diabetic patients: a possible correlation with fatty acid composition Mol Cell Biochem 199 63-67
[8]  
Parthasarathy S(1990)Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein (a) and very-low-density lipoprotein. Use of an antiserum against 4-hydroxynonenal-modified low-density lipoprotein Biochem J 265 605-608
[9]  
Steinberg D(2006)Plasma very-low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein oxidative modification induces procoagulant profiles in endogenous hypertriglyceridemia Free Radic Biol Med 40 1796-1803
[10]  
Witztum J(2002)Molecular and cellular interface between behavior and acute coronary syndromes Cardiovasc Res 56 15-21